期刊文献+

卵巢癌腹腔灌注化疗的近期疗效探讨

下载PDF
导出
摘要 目的探讨卵巢癌腹腔灌注化疗的近期疗效。方法将我院收治的符合条件的50例卵巢癌患者随机分为对照组和研究组,每组25例患者。对照组采取腹腔常温灌注化疗治疗,每周一次,连续治疗2-3周;研究组采取腹腔热灌注化疗治疗并联合SR-1000射频热疗机热疗,每周腹腔热灌注化疗一次,射频热疗治疗一次,连续治疗2-3周。对比两组腹水控制情况和生活治疗改善情况。结果对照组腹水控制总有效率为24%,研究组腹水控制总有效率为64%,差异具有统计学意义,P〈0.05。根据Karnofsky积分,对照组的生活质量在总改善率为28%,研究组为72%,差异具有统计学意义,P〈0.05。结论腹腔热灌注化疗联合射频热疗治疗效果明显优于单纯化疗,值得临床推广。
出处 《中国医药指南》 2015年第26期50-51,共2页 Guide of China Medicine
  • 相关文献

参考文献4

二级参考文献15

  • 1汪楣.癌治疗结果的报告标准[J].中华肿瘤杂志,1982,4(2):311-311.
  • 2Spratt JS,Adcock RA,Muxcovin M,et al.Clinical delivery system for intraperitoneal hyperthermic chemotherapy[J].Cancer Res.1980,40(2):256-260.
  • 3Fujunoto S,Takahashi M,Mutou T,et al.Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery[J].Cancer,1997,79(5):884-891.
  • 4Yonemura Y,Ninomiya I,Kaji M,et al.Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer[J].World Surg,1995,19(3):450-454.
  • 5Sugarbaker HP.Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis[J].Dis Colin Rectum,1994,37(2):S115-122.
  • 6Nicoletto MO,Padrini R,Galeotti F,et al.Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer[J].Cancer Chemother Pharmacol,2000,45(6):457-462.
  • 7Inoue Y,Yamashiro H,Sawada T,et al.Therapeutic results and pharmacokinetics of combined used anticancer drug in intraperitoneal hyperthermochemotherapy[J].Gan To Kagaku Ryoho,1990,17(8 Pt 2):1551-1554.
  • 8Spratt JS, Adcock RA, Muscovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy [ J]. Cancer Res, 1980, 40 (2) : 256 -260.
  • 9Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery[ J]. Cancer, 1997,79 (5) :884 - 891.
  • 10Alberts DS, Lui PY, Hannigan EV,et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage Ⅲ ovarian cancer[J]. N Engl J Med, 1996,335(26) :1950 - 1955.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部